Advancements in Triple-negative Breast Cancer Sub-typing, Diagnosis and Treatment with Assistance of Artificial Intelligence : a Focused Review

Overview

Journal J Cancer Res Clin Oncol

Specialty Oncology

Date 2024 Aug 5

PMID 39103624

Authors

Zahra Batool

Mohammad Amjad Kamal

Bairong Shen

Affiliations

Soon will be listed here.

Abstract

Triple negative breast cancer (TNBC) is most aggressive type of breast cancer with multiple invasive sub-types and leading cause of women's death worldwide. Lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) causes it to spread rapidly making its treatment challenging due to unresponsiveness towards anti-HER and endocrine therapy. Hence, needing advanced therapeutic treatments and strategies in order to get better recovery from TNBC. Artificial intelligence (AI) has been emerged by giving its high inputs in the automated diagnosis as well as treatment of several diseases, particularly TNBC. AI based TNBC molecular sub-typing, diagnosis as well as therapeutic treatment has become successful now days. Therefore, present review has reviewed recent advancements in the role and assistance of AI particularly focusing on molecular sub-typing, diagnosis as well as treatment of TNBC. Meanwhile, advantages, certain limitations and future implications of AI assistance in the TNBC diagnosis and treatment are also discussed in order to fully understand readers regarding this issue.

Citing Articles

Potential Therapeutic Targets in Triple-Negative Breast Cancer Based on Gene Regulatory Network Analysis: A Comprehensive Systems Biology Approach.

Ahmadi M, Barkhoda N, Alizamir A, Taherkhani A Int J Breast Cancer. 2024; 2024:8796102.

PMID: 39473450 PMC: 11521586. DOI: 10.1155/2024/8796102.

References

Valieris R, Amaro L, Osorio C, Bueno A, Rosales Mitrowsky R, Carraro D . Deep Learning Predicts Underlying Features on Pathology Images with Therapeutic Relevance for Breast and Gastric Cancer. Cancers (Basel). 2020; 12(12). PMC: 7763049. DOI: 10.3390/cancers12123687. View

Jiang Y, Yang M, Wang S, Li X, Sun Y . Emerging role of deep learning-based artificial intelligence in tumor pathology. Cancer Commun (Lond). 2020; 40(4):154-166. PMC: 7170661. DOI: 10.1002/cac2.12012. View

Al-Thelaya K, Gilal N, Alzubaidi M, Majeed F, Agus M, Schneider J . Applications of discriminative and deep learning feature extraction methods for whole slide image analysis: A survey. J Pathol Inform. 2023; 14:100335. PMC: 10622844. DOI: 10.1016/j.jpi.2023.100335. View

Ullah R, Khan S, Chaudhary I, Shahzad S, Ali H, Bilal M . Cost effective and efficient screening of tuberculosis disease with Raman spectroscopy and machine learning algorithms. Photodiagnosis Photodyn Ther. 2020; 32:101963. DOI: 10.1016/j.pdpdt.2020.101963. View

Pandy J, Balolong-Garcia J, Cruz-Ordinario M, Que F . Triple negative breast cancer and platinum-based systemic treatment: a meta-analysis and systematic review. BMC Cancer. 2019; 19(1):1065. PMC: 6839096. DOI: 10.1186/s12885-019-6253-5. View

Kim J, Yu D, Kwon Y, Lee K, Sim S, Kong S . Genomic Characteristics of Triple-Negative Breast Cancer Nominate Molecular Subtypes That Predict Chemotherapy Response. Mol Cancer Res. 2019; 18(2):253-263. DOI: 10.1158/1541-7786.MCR-19-0453. View

Wang X, Du Y, Yang S, Zhang J, Wang M, Zhang J . RetCCL: Clustering-guided contrastive learning for whole-slide image retrieval. Med Image Anal. 2022; 83:102645. DOI: 10.1016/j.media.2022.102645. View

Liu J, Su R, Zhang J, Wei L . Classification and gene selection of triple-negative breast cancer subtype embedding gene connectivity matrix in deep neural network. Brief Bioinform. 2021; 22(5). DOI: 10.1093/bib/bbaa395. View

Huang Z, Shao W, Han Z, Alkashash A, De La Sancha C, Parwani A . Artificial intelligence reveals features associated with breast cancer neoadjuvant chemotherapy responses from multi-stain histopathologic images. NPJ Precis Oncol. 2023; 7(1):14. PMC: 9883475. DOI: 10.1038/s41698-023-00352-5. View

10.

Mendelson E . Artificial Intelligence in Breast Imaging: Potentials and Limitations. AJR Am J Roentgenol. 2018; 212(2):293-299. DOI: 10.2214/AJR.18.20532. View

11.

Kumar Y, Koul A, Singla R, Ijaz M . Artificial intelligence in disease diagnosis: a systematic literature review, synthesizing framework and future research agenda. J Ambient Intell Humaniz Comput. 2022; 14(7):8459-8486. PMC: 8754556. DOI: 10.1007/s12652-021-03612-z. View

12.

Ma M, Liu R, Wen C, Xu W, Xu Z, Wang S . Predicting the molecular subtype of breast cancer and identifying interpretable imaging features using machine learning algorithms. Eur Radiol. 2021; 32(3):1652-1662. DOI: 10.1007/s00330-021-08271-4. View

13.

Redjdal A, Bouaud J, Guezennec G, Gligorov J, Seroussi B . Reusing Decisions Made with One Decision Support System to Assess a Second Decision Support System: Introducing the Notion of Complex Cases. Stud Health Technol Inform. 2021; 281:649-653. DOI: 10.3233/SHTI210251. View

14.

Shamir S, Sasson A, Margolies L, Mendelson D . New Frontiers in Breast Cancer Imaging: The Rise of AI. Bioengineering (Basel). 2024; 11(5). PMC: 11117903. DOI: 10.3390/bioengineering11050451. View

15.

Kothari C, Osseni M, Agbo L, Ouellette G, Deraspe M, Laviolette F . Machine learning analysis identifies genes differentiating triple negative breast cancers. Sci Rep. 2020; 10(1):10464. PMC: 7320018. DOI: 10.1038/s41598-020-67525-1. View

16.

Hu H, Tong K, Tsang J, Ko C, Tam F, Loong T . Subtyping of triple-negative breast cancers: its prognostication and implications in diagnosis of breast origin. ESMO Open. 2024; 9(4):102993. PMC: 11024544. DOI: 10.1016/j.esmoop.2024.102993. View

17.

Tsou L, Yeh S, Ueng S, Chang C, Song J, Wu M . Comparative study between deep learning and QSAR classifications for TNBC inhibitors and novel GPCR agonist discovery. Sci Rep. 2020; 10(1):16771. PMC: 7545175. DOI: 10.1038/s41598-020-73681-1. View

18.

Tsopra R, Fernandez X, Luchinat C, Alberghina L, Lehrach H, Vanoni M . A framework for validating AI in precision medicine: considerations from the European ITFoC consortium. BMC Med Inform Decis Mak. 2021; 21(1):274. PMC: 8487519. DOI: 10.1186/s12911-021-01634-3. View

19.

Huang Y, Wei L, Hu Y, Shao N, Lin Y, He S . Multi-Parametric MRI-Based Radiomics Models for Predicting Molecular Subtype and Androgen Receptor Expression in Breast Cancer. Front Oncol. 2021; 11:706733. PMC: 8416497. DOI: 10.3389/fonc.2021.706733. View

20.

Albusayli R, Graham J, Pathmanathan N, Shaban M, Raza S, Minhas F . Artificial intelligence-based digital scores of stromal tumour-infiltrating lymphocytes and tumour-associated stroma predict disease-specific survival in triple-negative breast cancer. J Pathol. 2023; 260(1):32-42. DOI: 10.1002/path.6061. View